ANALYSIS OF CHANGES IN METABOLIC SYNDROME, TREATMENT TACTICS, AND THE NEED AND IMPORTANCE OF IMPROVING PHARMACOTHERAPY

Аннотация:

Insulin resistance, abdominal obesity, dyslipidemia, and hypertension are among the many interrelated risk factors that define metabolic syndrome, a complex metabolic disease. Together, these factors put people at higher risk for T2DM and CVD). Globally, metabolic syndrome has become more common as obesity and sedentary lifestyles have increased. The pathophysiology of metabolic syndrome is examined in this review, with a focus on how it contributes to the onset and advancement of T2DM and CVD. The significant public health burden that metabolic syndrome poses is shown by epidemiological statistics, which calls for efficient care and prevention measures. The usefulness of the existing screening instruments and diagnostic criteria in clinical practice is highlighted. Management methods encompass lifestyle adjustments, medication, and surgical therapies, each targeting distinct components of metabolic syndrome to decrease cardiovascular and metabolic risks. Emerging research directions to improve prevention and treatment outcomes are discussed along with the difficulties in detecting and treating metabolic syndrome. This study attempts to help healthcare professionals optimize patient care and advance public health measures to combat this prevalent syndrome by clarifying the complex link between metabolic syndrome, CVD, and type 2 diabetes. Metabolic syndrome stands alone as a risk factor for numerous adverse health consequences. To lower cardiovascular risk and avoid diabetes and its complications, each of its constituent parts should be managed with medication and behavioral modifications. The treatment of the illness itself requires further investigation. Although more research is required on how to treat metabolic syndrome as opposed to its components, a diagnosis of the condition may be helpful in encouraging patients to make lifestyle adjustments.